Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pembrolizumab in combination with adjuvant chemotherapy with or without radiotherapy for newly diagnosed endometrial cancer …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Endometrial Neoplasms | Phase 3 | Status: ACTIVE_NOT_RECRUITING